Pictet Asset Management
PACB icon

Pictet Asset Management’s Pacific Biosciences PACB Stock Holding History

Pictet Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,025
Closed -$31.9K – 2042
2025
Q1 		$31.9K Hold
27,025
– – ﹤0.01% 2000
2024
Q4 		$49.5K Hold
27,025
– – ﹤0.01% 2020
2024
Q3 		$45.9K Hold
27,025
– – ﹤0.01% 2003
2024
Q2 		$37K Hold
27,025
– – ﹤0.01% 1960
2024
Q1 		$101K Hold
27,025
– – ﹤0.01% 1880
2023
Q4 		$265K Hold
27,025
– – ﹤0.01% 1606
2023
Q3 		$226K Buy
+27,025
New +$309K ﹤0.01% 1630

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management's PACB Position: Q2 2025 in Review

Pictet Asset Management sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 27,025 shares — an estimated $31.9K sold.

Pictet Asset Management first reported a position in PACB in Q3 2023 and held it in 7 quarters. The position peaked at $265K in Q4 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Pictet Asset Management reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Pictet Asset Management sold 27,025 Pacific Biosciences shares in Q2 2025, an estimated $31.9K.
  • Pictet Asset Management first reported a position in Pacific Biosciences in Q3 2023 and held it in 7 quarters.
  • Pictet Asset Management's Pacific Biosciences position peaked at $265K in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Pictet Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.